Intellia Therapeutics reported a net margin of -1,396.57% for the quarter ended Jun 2026. These financial ratios cover 46 quarters of results from Mar 2015 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Ratios | Mar2015 | Jun2015 | Sep2015 | Dec2015 | Mar2016 | Jun2016 | Sep2016 | Dec2016 | Mar2017 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||||||||||||||||||||||||||||||||
| EBT Margin | -994.50% | -621.69% | -1,277.16% | -695.64% | -780.83% | -771.63% | -793.10% | -880.40% | -987.05% | 6,647.52% | -350.34% | -1,820.05% | -1,455.91% | -977.29% | -674.83% | -720.21% | -760.14% | -400.72% | -633.49% | -1,396.57% | ||||||||||||||||||||||||||
| EBIT Margin | -999.35% | -625.60% | -1,281.96% | -700.65% | -795.49% | -811.07% | -888.13% | -973.47% | -1,093.29% | 7,297.44% | -394.00% | -1,998.61% | -1,588.96% | -1,059.86% | -726.57% | -772.17% | -808.86% | -428.86% | -668.08% | -1,472.25% | ||||||||||||||||||||||||||
| EBITDA Margin | -999.35% | -625.60% | -1,281.96% | -700.65% | -795.49% | -811.07% | -888.13% | -973.47% | -1,093.29% | 7,297.44% | -394.00% | -1,998.61% | -1,588.96% | -1,059.86% | -726.57% | -772.17% | -808.86% | -428.86% | -668.08% | -1,472.25% | ||||||||||||||||||||||||||
| Operating Margin | -999.35% | -625.60% | -1,281.96% | -700.65% | -795.49% | -811.07% | -888.13% | -973.47% | -1,093.29% | 7,297.44% | -394.00% | -1,998.61% | -1,588.96% | -1,059.86% | -726.57% | -772.17% | -808.86% | -428.86% | -668.08% | -1,472.25% | ||||||||||||||||||||||||||
| Net Margin | -994.50% | -621.69% | -1,277.16% | -695.64% | -780.83% | -771.63% | -793.10% | -880.40% | -987.05% | 6,647.52% | -350.34% | -1,820.05% | -1,455.91% | -977.29% | -674.83% | -720.21% | -760.14% | -400.72% | -633.49% | -1,396.57% | ||||||||||||||||||||||||||
| FCF Margin | -965.57% | -447.48% | -742.29% | -618.52% | -623.87% | -690.94% | -897.67% | -696.07% | -881.53% | 4,933.44% | -425.67% | -850.91% | -945.19% | -669.38% | -900.13% | -701.02% | -558.18% | -301.56% | -780.34% | -1,108.79% | ||||||||||||||||||||||||||
| Efficiency | ||||||||||||||||||||||||||||||||||||||||||||||
| Assets AverageAssets Avg. | 1.00B | 1.31B | 1.25B | 1.16B | 1.10B | 1.30B | 1.47B | 1.37B | 1.28B | 1.27B | 1.28B | 1.23B | 1.18B | 1.18B | 1.09B | 0.94B | 0.91B | 0.88B | 0.80B | 0.81B | ||||||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.03 | 0.03 | 0.03 | 0.04 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.06 | 0.06 | 0.08 | 0.08 | 0.07 | ||||||||||||||||||||||||||
| Valuation | ||||||||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | -139.20 | -110.21 | -38.24 | -40.31 | -41.38 | -29.02 | -32.84 | -30.10 | -23.80 | -22.25 | -26.14 | -17.37 | -15.77 | -9.46 | -6.56 | -9.63 | -19.09 | -11.34 | -16.20 | -22.15 | ||||||||||||||||||||||||||
| Price to SalesP/S | 0.00B | 685.17 | 488.41 | 280.38 | 323.07 | 223.90 | 260.46 | 265.03 | 234.93 | -0.00B | 91.59 | 316.19 | 229.60 | 92.41 | 44.28 | 69.36 | 145.09 | 45.43 | 102.61 | 309.32 | ||||||||||||||||||||||||||
| Price to BookP/B | 9.01 | 8.47 | 5.76 | 4.47 | 5.20 | 2.46 | 2.76 | 3.26 | 2.72 | 2.70 | 2.56 | 2.27 | 2.17 | 1.36 | 0.94 | -1.38 | 2.67 | 1.56 | 2.49 | 3.26 | ||||||||||||||||||||||||||
| Enterprise Value | 9.17B | 8.06B | 4.64B | 3.06B | 3.46B | 1.85B | 2.35B | 2.69B | 1.96B | 1.92B | 1.86B | 1.51B | 1.43B | 0.59B | 0.23B | 0.53B | 1.49B | 0.60B | 1.17B | 1.93B | ||||||||||||||||||||||||||
| EV to EBIT | -127.44 | -100.19 | -32.17 | -31.12 | -32.76 | -16.77 | -20.99 | -20.36 | -14.97 | -13.75 | -16.31 | -10.85 | -9.90 | -4.31 | -1.92 | -4.80 | -13.35 | -6.04 | -11.62 | -17.13 | ||||||||||||||||||||||||||
| EV to EBITDA | -127.44 | -100.19 | -32.17 | -31.12 | -32.76 | -16.77 | -20.99 | -20.36 | -14.97 | -13.75 | -16.31 | -10.85 | -9.90 | -4.31 | -1.92 | -4.80 | -13.35 | -6.04 | -11.62 | -17.13 | ||||||||||||||||||||||||||
| Market Capitalization | 9.97B | 8.81B | 5.50B | 3.93B | 4.29B | 3.04B | 3.28B | 3.60B | 2.82B | 2.84B | 2.65B | 2.20B | 2.09B | 1.19B | 0.74B | 0.99B | 2.00B | 1.05B | 1.54B | 2.37B | ||||||||||||||||||||||||||
| Price to FCFP/FCF | -143.37 | -153.12 | -65.80 | -45.33 | -51.78 | -32.41 | -29.01 | -38.08 | -26.65 | -29.98 | -21.52 | -37.16 | -24.29 | -13.81 | -4.92 | -9.89 | -25.99 | -15.07 | -13.15 | -27.90 | ||||||||||||||||||||||||||
| EV to FCF | -131.90 | -140.07 | -55.56 | -35.26 | -41.78 | -19.69 | -20.77 | -28.48 | -18.56 | -20.34 | -15.09 | -25.48 | -16.65 | -6.82 | -1.55 | -5.29 | -19.35 | -8.58 | -9.95 | -22.74 | ||||||||||||||||||||||||||
| EV to CFO | -141.10 | -147.42 | -58.15 | -35.96 | -44.03 | -20.55 | -21.49 | -29.83 | -19.36 | -20.67 | -15.41 | -25.93 | -16.90 | -6.90 | -1.56 | -5.30 | -19.36 | -8.60 | -9.95 | -23.24 | ||||||||||||||||||||||||||
| Return Ratios | ||||||||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | -999.35% | -625.60% | -1,281.96% | -700.65% | -795.49% | -811.07% | -888.13% | -973.47% | -1,093.29% | 7,297.44% | -394.00% | -1,998.61% | -1,588.96% | -1,059.86% | -726.57% | -772.17% | -808.86% | -428.86% | -668.08% | -1,472.25% | ||||||||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -25.37% | -22.53% | -32.58% | -38.24% | -44.34% | -38.97% | -31.19% | -36.19% | -40.75% | -44.54% | -43.75% | -46.77% | -49.94% | -49.87% | -55.44% | -60.45% | -58.50% | -56.55% | -58.11% | -58.12% | ||||||||||||||||||||||||||
| Return on Assets [ROA]ROA | -22.80% | -20.28% | -29.16% | -33.97% | -38.71% | -34.53% | -27.63% | -31.23% | -34.50% | -36.59% | -36.46% | -38.66% | -41.28% | -41.15% | -45.68% | -50.21% | -48.83% | -46.60% | -49.34% | -49.42% |